Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension.

Coons, James C; Bunner, Cheryl; Ishizawar, David C; Risbano, Michael G; Rivera-Lebron, Belinda; Mathier, Michael A; Chan, Stephen Y; Simon, Marc A.

Afiliação

Coons JC; 1 University of Pittsburgh School of Pharmacy, UPMC Presbyterian University Hospital, Pittsburgh, PA, USA.
Bunner C; 2 25817 Heart and Vascular Institute, University of Pittsburgh Medical Center , Pittsburgh, PA, USA.
Ishizawar DC; 3 5506 Department of Medicine, Division of Cardiology , Medical College of Wisconsin, Milwaukee, WI, USA.
Risbano MG; 4 Division of 199716 Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh.
Rivera-Lebron B; 5 University of Pittsburgh Medical Center, Heart, Lung, Blood and Vascular Medicine Institute, Pittsburgh, PA, USA.
Mathier MA; 4 Division of 199716 Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh.
Chan SY; 5 University of Pittsburgh Medical Center, Heart, Lung, Blood and Vascular Medicine Institute, Pittsburgh, PA, USA.
Simon MA; 6 Heart and Vascular Institute, Section of Heart Failure and Pulmonary Hypertension, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Pulm Circ ; 8(1): 2045893217744512, 2018.

Article em En | MEDLINE | ID: mdl-29199910